Skip to main content
. 2020 Dec 23;12:13173–13184. doi: 10.2147/CMAR.S286275

Figure 5.

Figure 5

METTL14 inhibited the metastatic potential of HCC cells through regulating EGFR/PI3K/AKT signaling pathway. (A) Western blot analysis of the expression of EMT markers after siMETTL14 and siEGFR transfection. (B) Western blot analysis of the expression of p-EGFR, p-PI3K, and p-AKT after siMETTL14 and siEGFR transfection.